Royalty Pharma plc (RPRX) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 16.69B |
| Enterprise Value | 25.02B |
| P/E Ratio | 25.29 |
| PEG Ratio | 7.37 |
| Price/Sales Ratio | 10.7 |
| Price/Book Ratio | 3.97 |
| Enterprise/Revenue | 13.92 |
| Enterprise/EBITDA | 20.57 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
| Profit Margin | 0.32 |
| Operating Margin | 0.62 |
| Return On Assets | 0.04 |
| Return On Equity | 0.12 |
| Revenue | 2.38B |
| Revenue/Share | 5.7 |
| Gross Profit | 2.38B |
| EBITDA | 1.64B |
| Net Income | 770.95M |
| Diluted EPS | 1.8 |
| Total Cash | 836.99M |
| Total Cash/Share | 1.88 |
| Total Debt | 8.96B |
| Total Debt/Equity | 1.31 |
| Current Ratio | 1.29 |
| Book Value Per Share | 21.99 |
| 52-Week Change | 64.71 |
| 52-Week High | 64.38 |
| 52-Week Low | 35.92 |
| Moving Average 50 Days | 59.28 |
| Moving Average 200 Days | 52.02 |
| Average Volume | 3M |
| Shares Outstanding | 445.28M |
| % Held by Institutions | 83.18 |
| Trailing Annual Dividend Rate | 0.93 |
| Trailing Annual Dividend Yield | 1.52 |
| Payout Ratio | 0.49 |
| Last Split Factor | N/A |
| Last Split Date | N/A |